Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Enable is currently working with a number of pharmaceutical partners to conduct clinical trials and plan for joint commercial launch of their therapies in combination with the enFuse technology. The ...

Verve received FDA IND clearance for VERVE-102 to treat HeFH, adding new trial sites in the United States. Read more about ...

A speeding delivery agent reportedly crashed into an elderly couple in a Bengaluru neighborhood on Monday afternoon, leaving the woman, in her 60s, in severe pain. The incident has reignited concerns ...

Benchmark indices Nifty and Sensex traded marginally higher on March 25, thanks to support provided by IT stocks. However, ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

Engineers devised a way to deliver drugs such as contraceptives by injecting them as suspended crystals. Once under the skin, the crystals assemble into a drug depot that can last for months or years, ...

Bayer was ordered to pay more than $2 billion by a jury in a Georgia state court in the latest legal case surrounding alleged ...

Sensex, Nifty updates on 24 March 2025. The benchmark BSE Sensex jumped 1.4% to 77,984.38, while the NSE Nifty gained 1.32% ...

OSI Systems, Virpax Pharmaceuticals, and NVE are the three Nanotechnology stocks to watch today, according to MarketBeat’s stock screener tool. Nanotechnology stocks are equities in companies that ...

Learn more about whether Glaukos Corporation or PROCEPT BioRobotics Corporation is a better investment based on AAII's A+ ...